Editorial commentary: getting smart in how we pay for HCV drugs: KAOS vs CONTROL
- PMID: 25778748
- DOI: 10.1093/cid/civ221
Editorial commentary: getting smart in how we pay for HCV drugs: KAOS vs CONTROL
Keywords: HCV; cost; cost-effectiveness; pharmacy benefit managers; therapy.
Comment on
-
The cost-effectiveness, health benefits, and financial costs of new antiviral treatments for hepatitis C virus.Clin Infect Dis. 2015 Jul 15;61(2):157-68. doi: 10.1093/cid/civ220. Epub 2015 Mar 16. Clin Infect Dis. 2015. PMID: 25778747 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources